Claire Reiss, a major owner of Biocept, has just filed an initial statement of beneficial ownership where 14,012 shares of Biocept were declared. This form is usually filed as a prelude to receiving options or buying company shares, so there may be more to come from Reiss. Reiss operates out of San Diego, CA. Some additional info was provided as follows:
This amendment is being filed to include shares of Common Stock that were inadvertently omitted from the original Form 3 filing, as amended, and the subsequent Form 4 filing, as amended.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Biocept makes a similar move, sign up!
Other recent filings from the company include the following:
On February - Feb. 12, 2018
Sabby Healthcare Master Fund, Ltd. just issued a filing suggesting it has sold all of its Biocept - Feb. 1, 2018
On January - Jan. 30, 2018
Biocept just filed a prospectus, suggesting it plans to soon issue some securities - Jan. 26, 2018
Registration adding securities to prior Form S-1 registration [Rule 462(b)] - Jan. 26, 2018